• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Viruses . Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders

tetano

Editor, Senior Moderator
Viruses


. 2021 Jun 30;13(7):1277.
doi: 10.3390/v13071277.
Maternal and Neonatal Outcomes of SARS-CoV-2 Infection in a Cohort of Pregnant Women with Comorbid Disorders


Maria de Lourdes Benamor Teixeira[SUP] 1 2 [/SUP], Orlando da Costa Ferreira Júnior[SUP] 3 [/SUP], Esaú João[SUP] 1 [/SUP], Trevon Fuller[SUP] 1 2 [/SUP], Juliana Silva Esteves[SUP] 4 [/SUP], Wallace Mendes-Silva[SUP] 4 5 [/SUP], Carolina Carvalho Mocarzel[SUP] 4 [/SUP], Richard Araújo Maia[SUP] 3 [/SUP], Lídia Theodoro Boullosa[SUP] 3 [/SUP], Cássia Cristina Alves Gonçalves[SUP] 3 [/SUP], Patrícia Pontes Frankel[SUP] 4 [/SUP], Maria Isabel Fragoso da Silveira Gouvêa[SUP] 1 2 [/SUP]



Affiliations

Abstract

There are some reports and case series addressing Coronavirus Disease 2019 (COVID-19) infections during pregnancy in upper income countries, but there are few data on pregnant women with comorbid conditions in low and middle income Countries. This study evaluated the proportion and the maternal and neonatal outcomes associated with SARS-CoV-2 infection among pregnant women with comorbidities. Participants were recruited consecutively in order of admission to a maternity for pregnant women with comorbidities. Sociodemographic, clinical, and laboratory data were prospectively collected during hospitalization. Pregnant women were screened at entry: nasopharyngeal swabs were tested by RT-PCR; serum samples were tested for IgG antibodies against spike protein by ELISA. From April to June 2020, 115 eligible women were included in the study. The proportion of SARS-CoV-2 infection was 28.7%. The rate of obesity was 60.9%, vascular hypertension 40.0%, and HIV 21.7%. The most common clinical presentations were ageusia (21.2%), anosmia (18.2%), and fever (18.2%). Prematurity was higher among mothers who had a SARS-CoV-2 infection based on RT-PCR. There were two cases of fetal demise. We found a high proportion of COVID-19 among pregnant women with comorbidities. This underscores the importance of antenatal care during the pandemic to implement universal SARS-CoV-2 screening, precautionary measures, and the rollout of vaccination programs for pregnant women.

Keywords: HIV; SARS-CoV-2; obesity; obstetrics; pregnancy.
 
Back
Top Bottom